Hepatocellular cancer

Hepatocellular cancer is the most common type of primary liver cancer in adults. It is closely linked to people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection. Metabolic syndrome and non-alcoholic fatty liver disease are also increasingly recognized as risk factors for this type of cancer.

Showing all 6 results

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price from
Ramucirumab C595845	VEGFR2	Monoclonal Antibody	Cyramza®	10 mg/mL	–	2 mg	-80°C	03/2018	182,70 €	view product Max: 10 Min: 2 Step: 1
Ramucirumab C716603	VEGFR2	Monoclonal Antibody	Cyramza®	10 mg/mL	–	2 mg	-80°C	06/2018	182,70 €	view product Max: 10 Min: 2 Step: 1
Ramucirumab C776706	VEGFR2	Monoclonal Antibody	Cyramza®	10 mg/mL	–	2 mg	-80°C	08/2018	182,70 €	view product Max: 10 Min: 2 Step: 1
Ramucirumab C826012	VEGFR2	Monoclonal Antibody	Cyramza®	10 mg/mL	–	2 mg	-80°C	01/2019	182,70 €	view product Max: 10 Min: 2 Step: 1
Ramucirumab C856707	VEGFR2	Monoclonal Antibody	Cyramza®	10 mg/mL	–	2 mg	-80°C	12/2019	182,70 €	view product Max: 10 Min: 2 Step: 1
Ramucirumab C889214	VEGFR2	Monoclonal Antibody	Cyramza®	10 mg/mL	–	2 mg	-80°C	06/2020	182,70 €	view product Max: 8 Min: 2 Step: 1